BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vougogiannopoulou K, Corona A, Tramontano E, Alexis MN, Skaltsounis AL. Natural and Nature-Derived Products Targeting Human Coronaviruses. Molecules 2021;26:448. [PMID: 33467029 DOI: 10.3390/molecules26020448] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Horvat M, Avbelj M, Durán-Alonso MB, Banjanac M, Petković H, Iskra J. Antiviral Activities of Halogenated Emodin Derivatives against Human Coronavirus NL63. Molecules 2021;26:6825. [PMID: 34833917 DOI: 10.3390/molecules26226825] [Reference Citation Analysis]
2 Dawre S, Maru S. Human respiratory viral infections: Current status and future prospects of nanotechnology-based approaches for prophylaxis and treatment. Life Sci 2021;278:119561. [PMID: 33915132 DOI: 10.1016/j.lfs.2021.119561] [Reference Citation Analysis]
3 Liu Q, Wan J, Wang G. A survey on computational methods in discovering protein inhibitors of SARS-CoV-2. Brief Bioinform 2021:bbab416. [PMID: 34623382 DOI: 10.1093/bib/bbab416] [Reference Citation Analysis]
4 Sharad S, Kapur S. Indian Herb-Derived Phytoconstituent-Based Antiviral, Antimicrobial and Antifungal Formulation: An Oral Rinse Candidate for Oral Hygiene and the Potential Prevention of COVID-19 Outbreaks. Pathogens 2021;10:1130. [PMID: 34578161 DOI: 10.3390/pathogens10091130] [Reference Citation Analysis]
5 Rizzuti B, Grande F, Conforti F, Jimenez-Alesanco A, Ceballos-Laita L, Ortega-Alarcon D, Vega S, Reyburn HT, Abian O, Velazquez-Campoy A. Rutin Is a Low Micromolar Inhibitor of SARS-CoV-2 Main Protease 3CLpro: Implications for Drug Design of Quercetin Analogs. Biomedicines 2021;9:375. [PMID: 33918402 DOI: 10.3390/biomedicines9040375] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
6 Khursheed A, Jain V, Rasool A, Rather MA, Malik NA, Shalla AH. Molecular scaffolds from mother nature as possible lead compounds in drug design and discovery against coronaviruses: A landscape analysis of published literature and molecular docking studies. Microb Pathog 2021;157:104933. [PMID: 33984466 DOI: 10.1016/j.micpath.2021.104933] [Reference Citation Analysis]
7 Bereczki I, Papp H, Kuczmog A, Madai M, Nagy V, Agócs A, Batta G, Milánkovits M, Ostorházi E, Mitrović A, Kos J, Zsigmond Á, Hajdú I, Lőrincz Z, Bajusz D, Keserű GM, Hodek J, Weber J, Jakab F, Herczegh P, Borbás A. Natural Apocarotenoids and Their Synthetic Glycopeptide Conjugates Inhibit SARS-CoV-2 Replication. Pharmaceuticals (Basel) 2021;14:1111. [PMID: 34832893 DOI: 10.3390/ph14111111] [Reference Citation Analysis]
8 Tietjen I, Cassel J, Register ET, Zhou XY, Messick TE, Keeney F, Lu LD, Beattie KD, Rali T, Tebas P, Ertl HCJ, Salvino JM, Davis RA, Montaner LJ. The Natural Stilbenoid (-)-Hopeaphenol Inhibits Cellular Entry of SARS-CoV-2 USA-WA1/2020, B.1.1.7, and B.1.351 Variants. Antimicrob Agents Chemother 2021;65:e0077221. [PMID: 34543092 DOI: 10.1128/AAC.00772-21] [Reference Citation Analysis]
9 Guijarro-Real C, Plazas M, Rodríguez-Burruezo A, Prohens J, Fita A. Potential In Vitro Inhibition of Selected Plant Extracts against SARS-CoV-2 Chymotripsin-Like Protease (3CLPro) Activity. Foods 2021;10:1503. [PMID: 34209659 DOI: 10.3390/foods10071503] [Reference Citation Analysis]
10 Rauf A, Rashid U, Khalil AA, Khan SA, Anwar S, Alafnan A, Alamri A, Rengasamy KR. Docking-based virtual screening and identification of potential COVID-19 main protease inhibitors from brown algae. S Afr J Bot 2021. [PMID: 34226782 DOI: 10.1016/j.sajb.2021.06.033] [Reference Citation Analysis]